Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Prostate Cancer

Prostate Cancer

Find a Physician


Quickly search our world-class physicians and faculty by keyword, location and insurance provider.


Prostate Cancer

Christopher E. Barbieri

Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer.

Douglas Scherr

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy, as well as a focused research effort.  As a Professor of Urology and the Clinical Director of Urologic Oncology, I continually interact with colleagues in the areas of medical oncology, radiation oncology, and pathology, among others, in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer.

Jim C. Hu

Dr. Jim Hu is a urologic oncologist with his undergraduate degree in Economics, his Master’s in Public Health in HealtPolicy and Management from Johns Hopkins University, and his Medical Degree from Baylor College of Medicine. He completed his Urology Residency at the David Geffen School of Medicine at UCLA and his Robotic Surgery/Urologic Oncology Fellowship in 2004 at City of Hope National Medical Center.

Prostate Cancer - Treatment Options

An individual's treatment path for prostate cancer is determined after assessing the risk level of your disease. Treatment paths are also greatly influenced by age and lifestyle of an individual with prostate cancer. For example, a 40 year old man diagnosed with early stage & low-risk prostate cancer may still decide to opt for a robotic prostatectomy to eliminate lifelong surveillance / watchful waiting.

Prostate Cancer - Diagnosis

For men with an abnormal PSA, there are now additional tests that may be considered before prostate needle biopsy. These include prostate Magnetic Resonance Imaging (MRI) and other genomic tests such as the 4k test and the Prostate Health Index (PHI).

Prostate Cancer - Risks & Causes

Older age is a risk factor for prostate cancer. Autopsy studies have shown that 30% of men in the 5th decade of life have evidence of prostate cancer versus 50% of men in the 8th decade of life. In the United States, 60% of men with prostate cancer are diagnosed after the age of 65 years.

Prostate Cancer

Prostate cancer is the second leading cause of cancer-related death in men. However, many men who are diagnosed with prostate cancer may be at low risk. Urologists at Weill Cornell Medicine help you understand your risks, and will provide evaluation for your specific circumstances. When pursuing treatment, we offer the most advanced treatment options including surgery, radiation therapy, and androgen deprivation therapy.

Peter N. Schlegel

Dr. Schlegel is an internationally acclaimed expert in the treatment of male infertility, especially the interface of male factor treatment with assisted reproductive techniques. His work has also clarified the importance of hormonal therapy, sperm analysis and genetic studies in the evaluation of men with infertility. He was awarded the 1996 Established Clinician Award by The European Society for Human Reproduction and Embryology.


Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.